Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum
- 18 January 2002
- journal article
- Published by Wiley in FEBS Letters
- Vol. 513 (2-3) , 159-162
- https://doi.org/10.1016/s0014-5793(02)02241-x
Abstract
F1000Prime Recommended Article: Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum.Keywords
This publication has 16 references indexed in Scilit:
- Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targetsPublished by Elsevier ,2001
- The aspartic proteinase from the rodent parasitePlasmodium bergheias a potential model for plasmepsins from the human malaria parasite,Plasmodium falciparumFEBS Letters, 1999
- Naturally‐occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium f alciparumFEBS Letters, 1999
- Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from plasmodium falciparum.Nature Structural & Molecular Biology, 1999
- Expression and Characterisation of Plasmepsin I from Plasmodium falciparumEuropean Journal of Biochemistry, 1997
- Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.Proceedings of the National Academy of Sciences, 1996
- High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparumFEBS Letters, 1994
- Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.Journal of Clinical Investigation, 1994
- Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease.The Journal of Experimental Medicine, 1991
- A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.Journal of Clinical Investigation, 1988